DHEA for Aging
High-quality trials show DHEA supplements do not slow aging or meaningfully improve body composition, strength, or vitality. DHEA is a hormone (a prescription drug in many countries), and major clinics advise against using it for anti-aging.
Why this grade7-layer evidence engine
The grade is D (Counter-Evidence) because the best clinical evidence is consistently null. The landmark 2-year double-blind Mayo/NIA randomized trial in 144 older adults with low DHEA-S (Nair et al., NEJM, PMID 17050889) found no meaningful effect on body composition, peak VO2, muscle strength, insulin sensitivity, or quality of life, with only a tiny, inconsistent change in bone density.
Two meta-analyses confirm the picture. A 2020 pooled analysis (PMID 32745490) found only marginal shifts in lean mass (+0.45 kg) and fat mass (-0.85%), with no change in body weight, BMI, or blood pressure. A 2013 meta-analysis of 25 trials in older men (n=1353, PMID 23824417) found the fat-mass reduction vanished after adjusting for downstream testosterone and estradiol, with no benefit to metabolic, bone, sexual, or quality-of-life outcomes. No trial shows DHEA extends lifespan or reverses aging.
Regulators and clinics reinforce this. The FDA's only DHEA-based approval is prasterone (Intrarosa) for postmenopausal painful sex, not anti-aging; the UK NHS classes DHEA as a prescription-only, controlled drug; and WADA bans it as an anabolic agent. Mayo Clinic states research has not proven anti-aging claims and warns the risks may outweigh any benefit, a position echoed by Cleveland Clinic and Harvard Health.
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditable▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.345
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高階證據未達主導 (1 positive vs 1 negative),由 raw_score 決定
- tier_strict_requirement_check — Tier 條件達標,未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status